JP2024517443A5 - - Google Patents

Info

Publication number
JP2024517443A5
JP2024517443A5 JP2023566885A JP2023566885A JP2024517443A5 JP 2024517443 A5 JP2024517443 A5 JP 2024517443A5 JP 2023566885 A JP2023566885 A JP 2023566885A JP 2023566885 A JP2023566885 A JP 2023566885A JP 2024517443 A5 JP2024517443 A5 JP 2024517443A5
Authority
JP
Japan
Prior art keywords
cancer
unsubstituted
substituted
alkyl
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023566885A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517443A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SG2022/050251 external-priority patent/WO2022231520A1/en
Publication of JP2024517443A publication Critical patent/JP2024517443A/ja
Publication of JP2024517443A5 publication Critical patent/JP2024517443A5/ja
Pending legal-status Critical Current

Links

JP2023566885A 2021-04-29 2022-04-27 がんの治療に有用なモレファンチン誘導体 Pending JP2024517443A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10202104429U 2021-04-29
SG10202104429U 2021-04-29
PCT/SG2022/050251 WO2022231520A1 (en) 2021-04-29 2022-04-27 Molephantin derivatives useful in the treatment of cancer

Publications (2)

Publication Number Publication Date
JP2024517443A JP2024517443A (ja) 2024-04-22
JP2024517443A5 true JP2024517443A5 (https=) 2025-06-11

Family

ID=83848883

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023566885A Pending JP2024517443A (ja) 2021-04-29 2022-04-27 がんの治療に有用なモレファンチン誘導体

Country Status (7)

Country Link
US (1) US20250304544A1 (https=)
EP (1) EP4330241A4 (https=)
JP (1) JP2024517443A (https=)
CN (1) CN117377663A (https=)
AU (1) AU2022265461A1 (https=)
IL (1) IL308058A (https=)
WO (1) WO2022231520A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115919833A (zh) * 2023-01-31 2023-04-07 暨南大学附属第一医院（广州华侨医院） 一种CutC蛋白抑制剂及其应用
AU2024337402A1 (en) * 2023-09-06 2026-03-26 Nanyang Biologics Pte. Ltd. Collective synthesis of phantomolin family through total synthesis of the sesquiterpene lactone molephantin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3418724B2 (ja) * 2000-02-10 2003-06-23 国立医薬品食品衛生研究所長 セスキテルペノイド化合物及びそれを含む医薬
JP2005002050A (ja) * 2003-06-12 2005-01-06 Shiseido Co Ltd 美白剤及びこれを配合した皮膚外用剤
CN102000072A (zh) * 2009-09-01 2011-04-06 奇复康药物研发(苏州)有限公司 偶联有一氧化氮供体的抗肿瘤天然药物及其医药用途
CN103732586B (zh) * 2011-04-07 2016-02-03 南洋理工大学 作为抗癌剂的乙酰基丹参酮iia(ata)
WO2019040335A1 (en) * 2017-08-19 2019-02-28 University Of Rochester MICHELOLID DERIVATIVES, PREPARATION METHODS AND THEIR USE AS ANTICANCER AND ANTI-INFLAMMATORY AGENTS
CN111153910B (zh) * 2020-01-09 2021-07-30 沈阳药科大学 地胆草种内酯衍生物及其制备方法和用途

Similar Documents

Publication Publication Date Title
JP6294277B2 (ja) Ｈｅｃ１活性の調節因子およびそのための方法
JP2020517616A5 (https=)
JP2024517443A5 (https=)
JP2021519783A5 (https=)
JP2020502103A5 (https=)
JP2019529490A5 (https=)
JP2021523225A5 (https=)
CA2889389C (en) Benzene sulfonamide thiazole compounds
HRP20161478T1 (hr) Inhibitori protein kinaze (varijante), njihova upotreba za liječenje neuroloških bolesti, kao i farmaceutski pripravak koji se na njima temelji
JP2015508092A5 (https=)
JP2014508811A5 (https=)
JP2014530243A (ja) Ａｒｒｙ−３８０の多形体、選択的ｈｅｒｂ２阻害剤、およびそれらを含有する薬学的組成物
JP2017504576A5 (https=)
JP2024511996A5 (https=)
JP2012528105A5 (https=)
JP6380777B2 (ja) ＰＩ３Ｋ、ｍＴＯＲ阻害薬としての縮合キノリン化合物
JP2022071077A5 (https=)
JP2025502943A5 (https=)
JP2020506970A5 (https=)
JP2017506267A5 (https=)
JP2019522681A5 (https=)
JP6913955B2 (ja) ＰＩ３Ｋ／ｍＴＯＲ阻害剤としての溶融キノリン化合物
JP2019522048A5 (https=)
JP2021532183A5 (https=)
JP2005531563A5 (https=)